Analysis of the Effect of Korean Red Ginseng on Retinal Blood Flow of Diabetic Retinopathy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0010991

Enrollment

Registered

2025-09-09

Start date

2021-04-20

Completion date

Unknown

Last updated

2025-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : The investigational product used in this study is Red Ginseng Tablet (500 mg), and the placebo is a matched Red Ginseng Tablet (placebo, 500 mg). Participants in both the interven

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients diagnosed with mild to moderate non-proliferative diabetic retinopathy

Exclusion criteria

Exclusion criteria: 1) pregnant or lactating women and children; 2) patients with comorbid ocular diseases that may significantly affect visual acuity or CMT, such as glaucoma, age-related macular degeneration, or branch retinal vein occlusion; 3) patients with a history of ocular trauma or surgery; 4) patients taking medications other than antihypertensive or antidiabetic agents; 5) patients with severe diabetic ocular complications, including PDR, DME, or neovascular glaucoma; and 6) patients taking circulatory-enhancing agents as adjunctive therapy for diabetes.

Design outcomes

Primary

Measure	Time frame
Best-Corrected Visual Acuity (BCVA), Central Macular Thickness (CMT), Intraocular Pressure (IOP), Optical Coherence Tomography Angiography (OCTA) parameters	—

Secondary

Measure	Time frame
Adverse events or complications	—

Countries

Korea, Republic of

Contacts

Public ContactDonghyun Lee

Yonsei University Health System, Gangnam Severance Hospital

wizmeca@live.co.kr+82-2-2019-3440

Outcome results